Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuroblastoma Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Combination Chemotherapy
1.2.3 Monoclonal Antibody Therapy
1.2.4 Vaccine Therapy
1.2.5 Chimeric Antigen Receptor T-Cell Immunotherapy
1.2.6 Oncolytic Virus Therapy
1.3 Market by Application
1.3.1 Global Neuroblastoma Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neuroblastoma Treatment Market Perspective (2018-2029)
2.2 Neuroblastoma Treatment Growth Trends by Region
2.2.1 Global Neuroblastoma Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Neuroblastoma Treatment Historic Market Size by Region (2018-2024)
2.2.3 Neuroblastoma Treatment Forecasted Market Size by Region (2024-2029)
2.3 Neuroblastoma Treatment Market Dynamics
2.3.1 Neuroblastoma Treatment Industry Trends
2.3.2 Neuroblastoma Treatment Market Drivers
2.3.3 Neuroblastoma Treatment Market Challenges
2.3.4 Neuroblastoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuroblastoma Treatment Players by Revenue
3.1.1 Global Top Neuroblastoma Treatment Players by Revenue (2018-2024)
3.1.2 Global Neuroblastoma Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neuroblastoma Treatment Revenue
3.4 Global Neuroblastoma Treatment Market Concentration Ratio
3.4.1 Global Neuroblastoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuroblastoma Treatment Revenue in 2022
3.5 Neuroblastoma Treatment Key Players Head office and Area Served
3.6 Key Players Neuroblastoma Treatment Product Solution and Service
3.7 Date of Enter into Neuroblastoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuroblastoma Treatment Breakdown Data by Type
4.1 Global Neuroblastoma Treatment Historic Market Size by Type (2018-2024)
4.2 Global Neuroblastoma Treatment Forecasted Market Size by Type (2024-2029)
5 Neuroblastoma Treatment Breakdown Data by Application
5.1 Global Neuroblastoma Treatment Historic Market Size by Application (2018-2024)
5.2 Global Neuroblastoma Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Neuroblastoma Treatment Market Size (2018-2029)
6.2 North America Neuroblastoma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Neuroblastoma Treatment Market Size by Country (2018-2024)
6.4 North America Neuroblastoma Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neuroblastoma Treatment Market Size (2018-2029)
7.2 Europe Neuroblastoma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Neuroblastoma Treatment Market Size by Country (2018-2024)
7.4 Europe Neuroblastoma Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neuroblastoma Treatment Market Size (2018-2029)
8.2 Asia-Pacific Neuroblastoma Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Neuroblastoma Treatment Market Size by Region (2018-2024)
8.4 Asia-Pacific Neuroblastoma Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neuroblastoma Treatment Market Size (2018-2029)
9.2 Latin America Neuroblastoma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Neuroblastoma Treatment Market Size by Country (2018-2024)
9.4 Latin America Neuroblastoma Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuroblastoma Treatment Market Size (2018-2029)
10.2 Middle East & Africa Neuroblastoma Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Neuroblastoma Treatment Market Size by Country (2018-2024)
10.4 Middle East & Africa Neuroblastoma Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Seattle Children’s
11.1.1 Seattle Children’s Company Detail
11.1.2 Seattle Children’s Business Overview
11.1.3 Seattle Children’s Neuroblastoma Treatment Introduction
11.1.4 Seattle Children’s Revenue in Neuroblastoma Treatment Business (2018-2024)
11.1.5 Seattle Children’s Recent Development
11.2 CureSearch
11.2.1 CureSearch Company Detail
11.2.2 CureSearch Business Overview
11.2.3 CureSearch Neuroblastoma Treatment Introduction
11.2.4 CureSearch Revenue in Neuroblastoma Treatment Business (2018-2024)
11.2.5 CureSearch Recent Development
11.3 Texas Children’s
11.3.1 Texas Children’s Company Detail
11.3.2 Texas Children’s Business Overview
11.3.3 Texas Children’s Neuroblastoma Treatment Introduction
11.3.4 Texas Children’s Revenue in Neuroblastoma Treatment Business (2018-2024)
11.3.5 Texas Children’s Recent Development
11.4 NANT
11.4.1 NANT Company Detail
11.4.2 NANT Business Overview
11.4.3 NANT Neuroblastoma Treatment Introduction
11.4.4 NANT Revenue in Neuroblastoma Treatment Business (2018-2024)
11.4.5 NANT Recent Development
11.5 Sino Biopharmaceutical
11.5.1 Sino Biopharmaceutical Company Detail
11.5.2 Sino Biopharmaceutical Business Overview
11.5.3 Sino Biopharmaceutical Neuroblastoma Treatment Introduction
11.5.4 Sino Biopharmaceutical Revenue in Neuroblastoma Treatment Business (2018-2024)
11.5.5 Sino Biopharmaceutical Recent Development
11.6 Jiangsu Hengrui Medicine Co.,Ltd.
11.6.1 Jiangsu Hengrui Medicine Co.,Ltd. Company Detail
11.6.2 Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
11.6.3 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Introduction
11.6.4 Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Neuroblastoma Treatment Business (2018-2024)
11.6.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Development
11.7 Fosun Pharmaceutical
11.7.1 Fosun Pharmaceutical Company Detail
11.7.2 Fosun Pharmaceutical Business Overview
11.7.3 Fosun Pharmaceutical Neuroblastoma Treatment Introduction
11.7.4 Fosun Pharmaceutical Revenue in Neuroblastoma Treatment Business (2018-2024)
11.7.5 Fosun Pharmaceutical Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Neuroblastoma Treatment Introduction
11.8.4 Novartis Revenue in Neuroblastoma Treatment Business (2018-2024)
11.8.5 Novartis Recent Development
11.9 Juno Therapeutics
11.9.1 Juno Therapeutics Company Detail
11.9.2 Juno Therapeutics Business Overview
11.9.3 Juno Therapeutics Neuroblastoma Treatment Introduction
11.9.4 Juno Therapeutics Revenue in Neuroblastoma Treatment Business (2018-2024)
11.9.5 Juno Therapeutics Recent Development
11.10 Kite Pharma
11.10.1 Kite Pharma Company Detail
11.10.2 Kite Pharma Business Overview
11.10.3 Kite Pharma Neuroblastoma Treatment Introduction
11.10.4 Kite Pharma Revenue in Neuroblastoma Treatment Business (2018-2024)
11.10.5 Kite Pharma Recent Development
11.11 Adaptimmune
11.11.1 Adaptimmune Company Detail
11.11.2 Adaptimmune Business Overview
11.11.3 Adaptimmune Neuroblastoma Treatment Introduction
11.11.4 Adaptimmune Revenue in Neuroblastoma Treatment Business (2018-2024)
11.11.5 Adaptimmune Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Neuroblastoma Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Combination Chemotherapy
Table 3. Key Players of Monoclonal Antibody Therapy
Table 4. Key Players of Vaccine Therapy
Table 5. Key Players of Chimeric Antigen Receptor T-Cell Immunotherapy
Table 6. Key Players of Oncolytic Virus Therapy
Table 7. Global Neuroblastoma Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Neuroblastoma Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Neuroblastoma Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 10. Global Neuroblastoma Treatment Market Share by Region (2018-2024)
Table 11. Global Neuroblastoma Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Neuroblastoma Treatment Market Share by Region (2024-2029)
Table 13. Neuroblastoma Treatment Market Trends
Table 14. Neuroblastoma Treatment Market Drivers
Table 15. Neuroblastoma Treatment Market Challenges
Table 16. Neuroblastoma Treatment Market Restraints
Table 17. Global Neuroblastoma Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 18. Global Neuroblastoma Treatment Market Share by Players (2018-2024)
Table 19. Global Top Neuroblastoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroblastoma Treatment as of 2022)
Table 20. Ranking of Global Top Neuroblastoma Treatment Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Neuroblastoma Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Neuroblastoma Treatment Product Solution and Service
Table 24. Date of Enter into Neuroblastoma Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Neuroblastoma Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 27. Global Neuroblastoma Treatment Revenue Market Share by Type (2018-2024)
Table 28. Global Neuroblastoma Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Neuroblastoma Treatment Revenue Market Share by Type (2024-2029)
Table 30. Global Neuroblastoma Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 31. Global Neuroblastoma Treatment Revenue Market Share by Application (2018-2024)
Table 32. Global Neuroblastoma Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Neuroblastoma Treatment Revenue Market Share by Application (2024-2029)
Table 34. North America Neuroblastoma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Neuroblastoma Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 36. North America Neuroblastoma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Neuroblastoma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Neuroblastoma Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 39. Europe Neuroblastoma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Neuroblastoma Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Neuroblastoma Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 42. Asia-Pacific Neuroblastoma Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Neuroblastoma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Neuroblastoma Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 45. Latin America Neuroblastoma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Neuroblastoma Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Neuroblastoma Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 48. Middle East & Africa Neuroblastoma Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 49. Seattle Children’s Company Detail
Table 50. Seattle Children’s Business Overview
Table 51. Seattle Children’s Neuroblastoma Treatment Product
Table 52. Seattle Children’s Revenue in Neuroblastoma Treatment Business (2018-2024) & (US$ Million)
Table 53. Seattle Children’s Recent Development
Table 54. CureSearch Company Detail
Table 55. CureSearch Business Overview
Table 56. CureSearch Neuroblastoma Treatment Product
Table 57. CureSearch Revenue in Neuroblastoma Treatment Business (2018-2024) & (US$ Million)
Table 58. CureSearch Recent Development
Table 59. Texas Children’s Company Detail
Table 60. Texas Children’s Business Overview
Table 61. Texas Children’s Neuroblastoma Treatment Product
Table 62. Texas Children’s Revenue in Neuroblastoma Treatment Business (2018-2024) & (US$ Million)
Table 63. Texas Children’s Recent Development
Table 64. NANT Company Detail
Table 65. NANT Business Overview
Table 66. NANT Neuroblastoma Treatment Product
Table 67. NANT Revenue in Neuroblastoma Treatment Business (2018-2024) & (US$ Million)
Table 68. NANT Recent Development
Table 69. Sino Biopharmaceutical Company Detail
Table 70. Sino Biopharmaceutical Business Overview
Table 71. Sino Biopharmaceutical Neuroblastoma Treatment Product
Table 72. Sino Biopharmaceutical Revenue in Neuroblastoma Treatment Business (2018-2024) & (US$ Million)
Table 73. Sino Biopharmaceutical Recent Development
Table 74. Jiangsu Hengrui Medicine Co.,Ltd. Company Detail
Table 75. Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
Table 76. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product
Table 77. Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Neuroblastoma Treatment Business (2018-2024) & (US$ Million)
Table 78. Jiangsu Hengrui Medicine Co.,Ltd. Recent Development
Table 79. Fosun Pharmaceutical Company Detail
Table 80. Fosun Pharmaceutical Business Overview
Table 81. Fosun Pharmaceutical Neuroblastoma Treatment Product
Table 82. Fosun Pharmaceutical Revenue in Neuroblastoma Treatment Business (2018-2024) & (US$ Million)
Table 83. Fosun Pharmaceutical Recent Development
Table 84. Novartis Company Detail
Table 85. Novartis Business Overview
Table 86. Novartis Neuroblastoma Treatment Product
Table 87. Novartis Revenue in Neuroblastoma Treatment Business (2018-2024) & (US$ Million)
Table 88. Novartis Recent Development
Table 89. Juno Therapeutics Company Detail
Table 90. Juno Therapeutics Business Overview
Table 91. Juno Therapeutics Neuroblastoma Treatment Product
Table 92. Juno Therapeutics Revenue in Neuroblastoma Treatment Business (2018-2024) & (US$ Million)
Table 93. Juno Therapeutics Recent Development
Table 94. Kite Pharma Company Detail
Table 95. Kite Pharma Business Overview
Table 96. Kite Pharma Neuroblastoma Treatment Product
Table 97. Kite Pharma Revenue in Neuroblastoma Treatment Business (2018-2024) & (US$ Million)
Table 98. Kite Pharma Recent Development
Table 99. Adaptimmune Company Detail
Table 100. Adaptimmune Business Overview
Table 101. Adaptimmune Neuroblastoma Treatment Product
Table 102. Adaptimmune Revenue in Neuroblastoma Treatment Business (2018-2024) & (US$ Million)
Table 103. Adaptimmune Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuroblastoma Treatment Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Neuroblastoma Treatment Market Share by Type: 2022 VS 2029
Figure 3. Combination Chemotherapy Features
Figure 4. Monoclonal Antibody Therapy Features
Figure 5. Vaccine Therapy Features
Figure 6. Chimeric Antigen Receptor T-Cell Immunotherapy Features
Figure 7. Oncolytic Virus Therapy Features
Figure 8. Global Neuroblastoma Treatment Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Neuroblastoma Treatment Market Share by Application: 2022 VS 2029
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Neuroblastoma Treatment Report Years Considered
Figure 14. Global Neuroblastoma Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Neuroblastoma Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Neuroblastoma Treatment Market Share by Region: 2022 VS 2029
Figure 17. Global Neuroblastoma Treatment Market Share by Players in 2022
Figure 18. Global Top Neuroblastoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroblastoma Treatment as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Neuroblastoma Treatment Revenue in 2022
Figure 20. North America Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Neuroblastoma Treatment Market Share by Country (2018-2029)
Figure 22. United States Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Neuroblastoma Treatment Market Share by Country (2018-2029)
Figure 26. Germany Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Neuroblastoma Treatment Market Share by Region (2018-2029)
Figure 34. China Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Neuroblastoma Treatment Market Share by Country (2018-2029)
Figure 42. Mexico Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Neuroblastoma Treatment Market Share by Country (2018-2029)
Figure 46. Turkey Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Neuroblastoma Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Seattle Children’s Revenue Growth Rate in Neuroblastoma Treatment Business (2018-2024)
Figure 49. CureSearch Revenue Growth Rate in Neuroblastoma Treatment Business (2018-2024)
Figure 50. Texas Children’s Revenue Growth Rate in Neuroblastoma Treatment Business (2018-2024)
Figure 51. NANT Revenue Growth Rate in Neuroblastoma Treatment Business (2018-2024)
Figure 52. Sino Biopharmaceutical Revenue Growth Rate in Neuroblastoma Treatment Business (2018-2024)
Figure 53. Jiangsu Hengrui Medicine Co.,Ltd. Revenue Growth Rate in Neuroblastoma Treatment Business (2018-2024)
Figure 54. Fosun Pharmaceutical Revenue Growth Rate in Neuroblastoma Treatment Business (2018-2024)
Figure 55. Novartis Revenue Growth Rate in Neuroblastoma Treatment Business (2018-2024)
Figure 56. Juno Therapeutics Revenue Growth Rate in Neuroblastoma Treatment Business (2018-2024)
Figure 57. Kite Pharma Revenue Growth Rate in Neuroblastoma Treatment Business (2018-2024)
Figure 58. Adaptimmune Revenue Growth Rate in Neuroblastoma Treatment Business (2018-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed